Tesamorelin in Longevity Clinics: FDA-Approved Peptide or Off-Label Hype?
Tesamorelin has an FDA-approved HIV lipodystrophy indication, but not for longevity, ordinary weight loss, cognition, bodybuilding, or anti-aging.
Tesamorelin has an FDA-approved HIV lipodystrophy indication, but not for longevity, ordinary weight loss, cognition, bodybuilding, or anti-aging.
A buyer guide to UFC GYM's PWR Clinics announcement, gym-based longevity medicine, and what to verify before buying GLP-1, TRT, peptide, IV, or recovery programs.
Retatrutide is promising in obesity trials, but products sold as retatrutide outside trials have triggered liver-toxicity warnings. Here is how clinic buyers can separate legitimate care from grey-market peptide risk.
Longevity clinics are usually regulated through doctors, medicines, devices, diagnostics, premises, and advertising claims — not as one universal clinic category.
What the FDA's July meeting did and did not change for BPC-157, TB-500, MOTS-c, Semax, Epitalon and other peptides marketed by longevity clinics.
WLC withdrew its 2026 peptide-clinic ranking because provider flags, marketing sources, dose tables, prices, and a claimed FDA reclassification did not support a safe recommendation.
An HHS announcement prompted reports of a peptide reclassification. Later FDA records show why an announcement, compounding policy, drug approval, and clinical evidence are different questions.
Longevity Docs promotes evidence, supervision, and traceable peptide supply. FDA records show why patients and clinics must verify the ingredient, compounder, lot, and regulatory pathway.